HSBC Holdings
ATYR

HSBC Holdings’s aTyr Pharma ATYR Stock Holding History

HSBC Holdings’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.4K Buy
66,185
+47,971
+263% +$31.3K ﹤0.01% 2876
2026
Q1 		$13.9K Buy
18,214
+2,078
+13% +$1.75K ﹤0.01% 2864
2025
Q4 		$12.1K Sell
16,136
-3
-0% -$2 ﹤0.01% 2903
2025
Q3 		$11.8K Sell
16,139
-8,445
-34% -$38.3K ﹤0.01% 2680
2025
Q2 		$128K Buy
+24,584
New +$96.7K ﹤0.01% 2800

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HSBC Holdings's ATYR Position: Q2 2026 in Review

HSBC Holdings increased its aTyr Pharma (ATYR) stake by 263% in Q2 2026, buying an estimated $31.3K and bringing the position to 66,185 shares worth $38.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2876.

HSBC Holdings first reported a position in ATYR in Q2 2025 and has held it in 5 quarters since. The position peaked at $128K in Q2 2025. 89 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • HSBC Holdings held 66,185 shares of aTyr Pharma worth $38.4K as of Q2 2026.
  • HSBC Holdings bought 47,971 aTyr Pharma shares in Q2 2026, an estimated $31.3K.
  • aTyr Pharma made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2876 holding.
  • HSBC Holdings first reported a position in aTyr Pharma in Q2 2025 and has held it in 5 quarters since.
  • HSBC Holdings's aTyr Pharma position peaked at $128K in Q2 2025.
  • 89 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.